Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology.
Lead author Kenneth Saag, M.D., M.Sc., a professor in the UAB Division of Clinical Immunology and Rheumatology, said the new guidelines update strategies for treating RA with the goal of preventing joint damage and disability.
Rheumatoid Arthritis Implicated in Heart Disease Risk
A new study has shown that rheumatoid arthritis is an important cardiovascular disease risk factor.
Advertisement
The new recommendations do not strive to replace individualized medical decisions, Saag said. Instead, they are meant to guide rheumatologists and other health care workers toward the most updated recommendations. The last set of American College of Rheumatology RA treatment guidelines was published in 2002.
"The recommendations developed are not intended to be used in a 'cookbook' or prescriptive manner, or to limit a physician's clinical judgment," Saag said. "They provide guidance based on clinical evidence and expert panel input."
![Smoking and Stress Increases Rheumatoid Arthritis Risk]( "Smoking and Stress Increases Rheumatoid Arthritis Risk")
A new study has shown that consumption of oily fish is associated with a reduced risk of developing rheumatoid arthritis (RA), whereas psychosocial work stress and smoking is linked
The recommendations focus on several classes of anti-arthritic drugs, including a potent group of agents called disease-modifying anti-rheumatic drugs (DMARDs). Newer genetically engineered DMARDs called biologics often work in combination with earlier therapies. Many anti-arthritic drugs are designed to stop damaging inflammation, and biologics work to interrupt the chain of events that leads to inflammation.
Newer biologics called anti-TNF agents - adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade) - prevent the production of an immunity protein that plays a role in inflammation.
Some of the key recommendations include:
Source: Newswise
SRM
Smoking and Stress Increases Rheumatoid Arthritis Risk
A new study has shown that consumption of oily fish is associated with a reduced risk of developing rheumatoid arthritis (RA), whereas psychosocial work stress and smoking is linked
Advertisement
The recommendations focus on several classes of anti-arthritic drugs, including a potent group of agents called disease-modifying anti-rheumatic drugs (DMARDs). Newer genetically engineered DMARDs called biologics often work in combination with earlier therapies. Many anti-arthritic drugs are designed to stop damaging inflammation, and biologics work to interrupt the chain of events that leads to inflammation.
Newer biologics called anti-TNF agents - adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade) - prevent the production of an immunity protein that plays a role in inflammation.
Some of the key recommendations include:
- Methotrexate or leflunomide therapy is recommended for most RA patients.
- Anti-TNF agents etanercept, infliximab, or adalimumab along with methotrexate can be used in new or early RA cases with worsening and severe symptoms.
- Doctors should not initiate or resume treatment with methotrexate, leflunomide, or biologics if RA patients have active bacterial infection, shingles (herpes-zoster), hepatitis B, hepatitis C and active or latent tuberculosis.
Source: Newswise
SRM
Moderate Alcohol Consumption Lessens Rheumatoid Arthritis Risk
People who drink alcohol are less prone to the sometimes crippling disease called rheumatoid arthritis compared with non-drinkers, according to a Scandinavian study published on Wednesday.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
The Pakistan Ministry has announced the commencement of a nationwide polio vaccination campaign beginning on October 2, aiming to immunize more children.
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
